Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:2:107.
doi: 10.3332/ecancer.2008.107. Epub 2008 Nov 12.

Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva

S Camporesi  1
Affiliations

Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva

S Camporesi. Ecancermedicalscience. 2008.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. FDA. Challenge and Opportunity On the Critical Path to New Medical Products. Mar, 2004. available at: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html (accessed 24 October 2008)
    1. FDA. 2006 Guidance for Industry, Investigators, and Reviewers Exploratory IND Studies. available at: http://www.fda.gov/CDER/guidance/7086fnl.htm (accessed 24 October 2008)
    1. EMEA. Position Paper on non-clinical safety studies to support clinical trials with a single microdose. Jun, 2004. http://www.emea.europa.eu/pdfs/human/swp/259902en.pdf (accessed 24 October 2008)
    1. Kummar S, Kinders R, Rubinstein L, et al. Compressing drug development timelines in oncology using phase ‘0’ trials. Nat Rev Cancer. 2007;7(2):131–9. doi: 10.1038/nrc2066. - DOI - PubMed
    1. Kinders R, Parchment RE, Ji J, et al. Phase 0 Clinical Trials in Cancer Drug Development: From FDA Guidance to Clinical Practice. Mol Interv. 2007;7(6):325–34. doi: 10.1124/mi.7.6.9. - DOI - PubMed

LinkOut - more resources